Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Bone Density × 90 days × Clear all

Phase

Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 108 Carboplatin 108 Cisplatin 101 Paclitaxel 82 Gemcitabine 75 Specimen Handling 68 Magnetic Resonance Spectroscopy 65 Docetaxel 57 Pemetrexed 52 Dexamethasone 52 Cyclophosphamide 51 Capecitabine 51 Radiotherapy 49 Oxaliplatin 49 Doxorubicin 45 Bevacizumab 44 Rituximab 42 Fluorouracil 40 durvalumab 39 Radiation 39 Lenalidomide 37 Leucovorin 36 Vincristine 34 atezolizumab 30 Etoposide 27 130-nm albumin-bound paclitaxel 27 Letrozole 26 Irinotecan 26 Prednisone 25 Trastuzumab 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05838716 2026-01-15

ViPER

University of Rochester

Phase 3 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡